Hypermethylation leads to down-regulated 14-3-3 sigma expression in nasopharyngeal carcinoma tissues*

Progress in Biochemistry and Biophysics

Volumn 36, Issue 6, 2009, Pages 743-749

  Tan, Shuang Xiang ^a,b   Jun, L I ^a   Hong, Y I ^a   Tang, Cen E ^a   Cheng, Ai Lan ^a   Chen, Zhu Chu ^a   Jian Ling, L I ^a   Zhi Qiang, Xiao ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Hunan Province Geriatric Hospital   (China)

Author keywords

Epigenetic; Gene expression; Methylation, stratifin; Words nasopharyngeal neoplasm

Indexed keywords

EID: 70349226808     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1206.2008.00690     Document Type: Article

References (19)

1. Gronbaek K, Hother C, Jones P A. Epigenetic changes in cancer. APMIS, 2007, 115(10): 1039-1059
2. Lodygin D, Hermeking H. Epigenetic silencing of 14-3-3sigma in cancer. Semin Cancer Biol, 2006, 16(3): 214-224
3. Lee M H, Lozano G. Regulation of the p53-MDM2 pathway by 14-3-3 sigma and other proteins. Semin Cancer Biol, 2006, 16(3): 225-234 (Pubitemid 43796127)
4. Yang H, Zhao R, Lee M H. 14-3-3sigma, a p53 regulator, suppresses tumor growth of nasopharyngeal carcinoma.Mol Cancer Ther, 2006, 5(2): 253-260
5. Cheng A L, Huang W G, Chen Z C, et al. Identification of novel nasopharyngeal carcinoma biomarkers by laser capture microdissection and proteomic analysis. Clin Cancer Res, 2008, 14 (2): 435-445
6. Akahira J, Sugihashi Y, Suzuki T, et al. Decreased expression of 14-3-3 sigma is associated with advanced disease in human epithelial ovarian cancer: its correlation with aberrant DNA methylation. Clin Cancer Res, 2004, 10(8): 2687-2693 (Pubitemid 38509143)
7. Perathoner A, Pirkebner D, Brandacher G, et al. 14-3-3σ Expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients. Clinical Cancer Research, 2005, 11 (9): 3274-3279
8. Morrison D K. The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development. Trends Cell Biol, 2009, 19(1): 16-23
9. Neupane D, Korc M. 14-3-3 {sigma} modulates pancreatic cancer cell survival and invasiveness. Clin Cancer Res, 2008, 14 (23): 7614-7623
10. Jing F, Jun L, Yong Z, et al. Multigene methylation in serum of sporadic Chinese female breast cancer patients as a prognostic biomarker. Oncology, 2008, 75(1-2): 60-66
11. Liang S, Xu Y, Shen G, et al. Gene expression and methylation status of 14-3-3sigma in human renal carcinoma tissues. IUBMB Life, 2008, 60(8): 534-540
12. Kunze E, Schlott T. High frequency of promoter methylation of the 14-3-3 sigma and CAGE-I genes, but lack of hypermethylation of the caveolin-1 gene, in primary adenocarcinomas and signet ring cell carcinomas of the urinary bladder. Int J Mol Med, 2007, 20 (4): 557-563
13. Horie-Inoue K, Inoue S. Epigenetic and proteolytic inactivation of 14-3-3sigma in breast and prostate cancers. Semin Cancer Biol, 2006, 16(3): 235-239 (Pubitemid 43796123)
14. Castedo M, Perfettini J L, Roumier T, et al. Cell death by mitotic catastrophe: a molecular definition. Oncogene, 2004, 23 (16): 2825-2837 (Pubitemid 38638845)
15. Wilker E W, van Vugt M A, Artim S A, et al. 14-3-3sigma controls mitotic translation to facilitate cytokinesis. Nature, 2007, 446 (7133): 329-332
16. Chen J C, Chen Y, Su Y H, et al. Celecoxib increased expression of 14-3-3sigma and induced apoptosis of glioma cells. Anticancer Res, 2007, 27(4B): 2547-2554 (Pubitemid 47232274)
17. Samuel T, Weber H O, Rauch P, et al. The G2/M regulator 14-3-3σ prevents apoptosis through sequestration of Bax. J Biol Chem, 2001, 276(48): 45201-45206 (Pubitemid 37391314)
18. Ide M, Saito K, Tsutsumi S, et al. Over-expression of 14-3-3sigma in budding colorectal cancer cells modulates cell migration in the presence of tenascin-C. Oncol Rep, 2007, 18(6): 1451-1456